相关实验视频
Updated: Jun 10, 2025

08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
14.5K
控制释放的迪诺普罗斯阴道插入剂在预产日期之前选择性诱导分娩的有效性
Junko Tamai1, Satoru Ikenoue1, Keisuke Akita1
1Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
The journal of obstetrics and gynaecology research
|October 14, 2024
概括
与机械方法相比,控制释放的迪诺普罗斯 (PGE2) 阴道插件显著增加了选择性劳动诱导的阴道分娩的成功率. 这种方法还减少了由于胎儿痛苦而导致的紧急剖腹产.
科学领域:
- 产科和妇科 产科和妇科
- 生殖医学 生殖医学
背景情况:
- 在预产日期之前选择性分娩诱导被证明可以减少剖腹产,而不会增加不良的围产期结果.
- 控制释放的迪诺普罗斯 (PGE2) 阴道插件在日本已获得批准,但对其在预期日期前诱导有效性的证据是有限的.
研究的目的:
- 为了比较dinoprostone (PGE2) 阴道插入与机械扩张的疗效,以便在产日之前引发分娩.
主要方法:
- 一项追溯的队列研究,对206名怀孕37-39周的母亲进行.
- 在PGE2插入组 (n=46) 和机械扩张组 (n=160) 之间比较周产期结果,包括阴道分娩成功率.
- 阴道分娩的成功定义为在催产素增强后48小时内分娩.
主要成果:
- 阴道分娩的成功率在PGE2组 (80.4%) 显著高于非PGE2组 (66.2%).
- 由于不令人放心的胎儿状况而导致的紧急剖腹产发生在5.0%的非PGE2组中,而PGE2组中没有.
结论:
- 阴道插入剂Dinoprostone (PGE2) 显著增加了怀孕37周至39周之间选择性劳动诱导的阴道分娩率.
- PGE2阴道插件可以提高阴道分娩的成功率,用于39周的选择性分娩诱导.
相关概念视频
Local Anesthetics: Clinical Application as Epidural Anesthesia
417
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
417
Drugs for Treatment of Constipation-Predominant IBS
140
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
140
Birth Control Methods
204
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
204
Parenteral Anesthetics: Overview
106
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
106
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
371
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
371
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
265
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
265

